These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 23221478)

  • 1. Successful TRPV1 antagonist treatment for cardiac hypertrophy and heart failure in mice.
    Horton JS; Buckley CL; Stokes AJ
    Channels (Austin); 2013 Jan; 7(1):17-22. PubMed ID: 23221478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. "TRPV1 is a component of the atrial natriuretic signaling complex, and using orally delivered antagonists, presents a valid therapeutic target in the longitudinal reversal and treatment of cardiac hypertrophy and heart failure".
    Horton JS; Shiraishi T; Alfulaij N; Small-Howard AL; Turner HC; Kurokawa T; Mori Y; Stokes AJ
    Channels (Austin); 2019 Dec; 13(1):1-16. PubMed ID: 30424709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mice lacking functional TRPV1 are protected from pressure overload cardiac hypertrophy.
    Buckley CL; Stokes AJ
    Channels (Austin); 2011; 5(4):367-74. PubMed ID: 21814047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic ablation of TRPV1 exacerbates pressure overload-induced cardiac hypertrophy.
    Zhong B; Rubinstein J; Ma S; Wang DH
    Biomed Pharmacother; 2018 Mar; 99():261-270. PubMed ID: 29334670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased transient receptor potential vanilloid type 1 (TRPV1) channel expression in hypertrophic heart.
    Thilo F; Liu Y; Schulz N; Gergs U; Neumann J; Loddenkemper C; Gollasch M; Tepel M
    Biochem Biophys Res Commun; 2010 Oct; 401(1):98-103. PubMed ID: 20833132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac-specific overexpression of caveolin-3 attenuates cardiac hypertrophy and increases natriuretic peptide expression and signaling.
    Horikawa YT; Panneerselvam M; Kawaraguchi Y; Tsutsumi YM; Ali SS; Balijepalli RC; Murray F; Head BP; Niesman IR; Rieg T; Vallon V; Insel PA; Patel HH; Roth DM
    J Am Coll Cardiol; 2011 May; 57(22):2273-83. PubMed ID: 21616289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dietary capsaicin ameliorates pressure overload-induced cardiac hypertrophy and fibrosis through the transient receptor potential vanilloid type 1.
    Wang Q; Ma S; Li D; Zhang Y; Tang B; Qiu C; Yang Y; Yang D
    Am J Hypertens; 2014 Dec; 27(12):1521-9. PubMed ID: 24858305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of transient receptor potential vanilloid 3 channel (TRPV3) aggravated pathological cardiac hypertrophy via calcineurin/NFATc3 pathway in rats.
    Zhang Q; Qi H; Cao Y; Shi P; Song C; Ba L; Chen Y; Gao J; Li S; Li B; Sun H
    J Cell Mol Med; 2018 Dec; 22(12):6055-6067. PubMed ID: 30299584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced insulin secretion and sensitization in diabetic mice on chronic treatment with a transient receptor potential vanilloid 1 antagonist.
    Tanaka H; Shimaya A; Kiso T; Kuramochi T; Shimokawa T; Shibasaki M
    Life Sci; 2011 Mar; 88(11-12):559-63. PubMed ID: 21277869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolevuglandin scavenger attenuates pressure overload-induced cardiac oxidative stress, cardiac hypertrophy, heart failure and lung remodeling.
    Shang L; Weng X; Wang D; Yue W; Mernaugh R; Amarnath V; Weir EK; Dudley SC; Xu Y; Hou M; Chen Y
    Free Radic Biol Med; 2019 Sep; 141():291-298. PubMed ID: 31254620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cold stress accentuates pressure overload-induced cardiac hypertrophy and contractile dysfunction: role of TRPV1/AMPK-mediated autophagy.
    Lu S; Xu D
    Biochem Biophys Res Commun; 2013 Dec; 442(1-2):8-15. PubMed ID: 24211590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hypertension-induced fibrosis: a balance story].
    Azibani F; Fazal L; Chatziantoniou C; Samuel JL; Delcayre C
    Ann Cardiol Angeiol (Paris); 2012 Jun; 61(3):150-5. PubMed ID: 22681982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The toll-like receptor 4-antagonist eritoran reduces murine cardiac hypertrophy.
    Ehrentraut H; Weber C; Ehrentraut S; Schwederski M; Boehm O; Knuefermann P; Meyer R; Baumgarten G
    Eur J Heart Fail; 2011 Jun; 13(6):602-10. PubMed ID: 21613426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The alteration of protein prenylation induces cardiomyocyte hypertrophy through Rheb-mTORC1 signalling and leads to chronic heart failure.
    Xu N; Guan S; Chen Z; Yu Y; Xie J; Pan FY; Zhao NW; Liu L; Yang ZZ; Gao X; Xu B; Li CJ
    J Pathol; 2015 Apr; 235(5):672-85. PubMed ID: 25385233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelial p53 deletion improves angiogenesis and prevents cardiac fibrosis and heart failure induced by pressure overload in mice.
    Gogiraju R; Xu X; Bochenek ML; Steinbrecher JH; Lehnart SE; Wenzel P; Kessel M; Zeisberg EM; Dobbelstein M; Schäfer K
    J Am Heart Assoc; 2015 Feb; 4(2):. PubMed ID: 25713289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac raptor ablation impairs adaptive hypertrophy, alters metabolic gene expression, and causes heart failure in mice.
    Shende P; Plaisance I; Morandi C; Pellieux C; Berthonneche C; Zorzato F; Krishnan J; Lerch R; Hall MN; Rüegg MA; Pedrazzini T; Brink M
    Circulation; 2011 Mar; 123(10):1073-82. PubMed ID: 21357822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolonged endoplasmic reticulum stress in hypertrophic and failing heart after aortic constriction: possible contribution of endoplasmic reticulum stress to cardiac myocyte apoptosis.
    Okada K; Minamino T; Tsukamoto Y; Liao Y; Tsukamoto O; Takashima S; Hirata A; Fujita M; Nagamachi Y; Nakatani T; Yutani C; Ozawa K; Ogawa S; Tomoike H; Hori M; Kitakaze M
    Circulation; 2004 Aug; 110(6):705-12. PubMed ID: 15289376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Puerarin attenuates pressure overload-induced cardiac hypertrophy.
    Yuan Y; Zong J; Zhou H; Bian ZY; Deng W; Dai J; Gan HW; Yang Z; Li H; Tang QZ
    J Cardiol; 2014 Jan; 63(1):73-81. PubMed ID: 23906530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The H19 long noncoding RNA is a novel negative regulator of cardiomyocyte hypertrophy.
    Liu L; An X; Li Z; Song Y; Li L; Zuo S; Liu N; Yang G; Wang H; Cheng X; Zhang Y; Yang X; Wang J
    Cardiovasc Res; 2016 Jul; 111(1):56-65. PubMed ID: 27084844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parallel gene expressions of IL-6 and BNP during cardiac hypertrophy complicated with diastolic dysfunction in spontaneously hypertensive rats.
    Haugen E; Chen J; Wikström J; Grönros J; Gan LM; Fu LX
    Int J Cardiol; 2007 Jan; 115(1):24-8. PubMed ID: 16762434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.